这类药物包括雅培制药公司的利普安、阿斯利康公司的高舍瑞林和赛诺菲·安万特集团的醋酸亮丙瑞林。

The medications include Abbott Laboratories inc's Lupron, AstraZeneca Plc's Zoladex and Sanofi-Aventis SA's Eligard.

youdao

她说，利普安的标签中也有提到糖尿病、血糖升高和心脏病，而公司也会按照FDA的要求，在药品说明中增加新的警告。

Diabetes, increases in blood sugar and heart problems already are mentioned on Lupron's label, and the company will comply with the FDA request to add the new warning, she said.

youdao